LATEST ALERTS
French e-liquid manufacturer Gaïatrend has strengthened its U.S. presence despite the uncertainty brought about by the FDA’s deeming regulations, and is confident they will be amended via one legal route or another.
A new U.S. study claiming to show a link between youth e-cigarette use and tobacco smoking has not only been criticised by many scientists working in the field, but also demonstrates how misconceptions and misinformation on the topic of vaping spread through the media.
Altria, the largest U.S. tobacco company, has written to the Food and Drug Administration (FDA) to protest its plans for e-cigarette product approvals.
A new study from North Dakota says few vape stores comply with the state’s public vaping laws.
The UK will launch a consultation on taxation for heat-not-burn products later this year.
New guidance on public-vaping policies from Public Health England (PHE) provides a detailed rationale for allowing e-cigarette use even where smoking is forbidden.
The American arm of a major Chinese e-cigarette coalition has chosen to join the Vapor Technology Association (VTA).
A motion to record grievances over the EU Tobacco Products Directive (TPD) and its UK implementation failed in the British House of Lords.
Swedish Match is contesting the European Union’s ban on snus in court.
At June’s Global Forum on Nicotine in Warsaw, ECigIntelligence editorial director Barnaby Page took a look at some of the inconsistencies that are emerging in European regulation of e-cigarettes despite the standardisation imposed by the EU Tobacco Products Directive (TPD). Here is his presentation.
British e-cigarette businesses have reacted cautiously to the UK referendum vote in favour of leaving the European Union, although some users have seen it as a triumph for vapers.
Cynthia Cabrera is stepping down as executive director, CEO and president of the Smoke Free Alternatives Trade Association (SFATA).
Contents1 Introduction2 Why an ENDS product requires FDA approval3 Pathways to approval4 The FDA guidance on PMTAs5 PMTAs, public health, and scientific studies There may be more recent ECigIntelligence reports on this territory. Please visit the home page for the United States or the advanced search page. Introduction On 10th May, the U.S. Food and Drug Administration (FDA) » Continue Reading.
Many questions remain over how the FDA will actually interpret the requirements for authorisation: how rigid a view it will take on the evidence required to support an application, for example. Comparing a leaked earlier version of the regulations with the final published version provides some clues.
Britain’s decision to leave the European Union following yesterday’s knife-edge referendum will have little immediate impact on either vapers or the industry.
The British Medical Association is going against the trend of UK professional medical bodies and sticking to a more sceptical line on e-cigarettes, backing a public vaping ban.
The World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) has been accused of ignoring its own founding document in taking a stance against e-cigarettes, as well as neglecting the governance principles of its ultimate parent the United Nations.
As Britain’s debate on whether to leave the European Union reaches fever pitch in anticipation of Thursday’s referendum, vapers and e-cigarette advocates are as divided as the split nation.
Stories about the poisonous threat of e-cigarettes have been hitting the headlines in recent years, particularly cases affecting young children, and the most serious incidents have involved fatalities. We take a look at the facts and figures.
Young vapers in the UK do not see e-cigarettes primarily as substitutes for conventional tobacco products and are attracted to them for different reasons, according to a new study.
The majority of American vapers were unaware of the new deeming regulations for e-cigarettes from the U.S. Food and Drug Administration (FDA) until they were published last month – and many may remain so, a new survey seems to imply.
As the tobacco industry braces itself for a global epidemic of plain-packaging legislation, there have been calls for the controversial measure to be applied to e-cigarettes too.
Two British members of the European Parliament have asked the EU to take the first steps in reassessing the scientific information that supports its Tobacco Products Directive (TPD).
Tobacco control leaders from around the globe will be presented with the latest findings of the World Health Organization (WHO) on e-cigarettes and public health at a meeting in India this November.
The attitudes of New Zealand’s policy-makers to e-cigarettes seem to be growing more liberal than those of their counterparts in Australia, with the smaller nation edging toward greater tolerance of vaping while the larger maintains an unforgiving stance.
Membership in a trade association is no guarantee that online e-cigarette sellers will adopt measures such as warning labels and age verification, according to a new U.S. study, despite industry bodies often arguing that their members lead the way.
Two new studies on the correlation between youth vaping and e-cigarette advertising are likely to be used to support calls for regulation of marketing – but they may add less to the debate than they seem, being based on the same previously-published numbers.
E-cigarettes, public health and regulation will again be high on the agenda for the annual Global Forum on Nicotine held in Poland next month.
The proposed Welsh public vaping ban is officially dead.
Two large hospitals in England have become the country’s first to reverse vaping bans.
A massive decline in Malaysian vaper numbers has been confirmed by a local industry organisation.
The final shape of France’s TPD transposition is becoming clearer following the presentation this week of an ordonnance to the Council of Ministers.
Much of the external influence on the TPD’s formulation came from the pharmaceutical sector – more than from the tobacco companies.
The EU’s new Tobacco Products Directive (TPD) and national legislation are broadly sufficient to protect the public from nicotine poisoning, an official European study has concluded. But it does recommend further consumer education on the risks of ingestion, as well as tight control of industrial nicotine.
The Republic of Ireland has succeeded in transposing the EU’s Tobacco Products Directive (TPD) at the eleventh hour, with recently-appointed health minister Simon Harris signing the necessary regulations to come into force today.
This page provides you with links to all ECigIntelligence coverage of the EU Tobacco Products Directive (TPD) since 1st January this year.
Nearly half of EU member states look likely to miss today’s deadline for fully transposing the Tobacco Products Directive (TPD) into local law.
We summarise the essential requirements of the EU Tobacco Products Directive for e-cigarette firms.
UK e-cig firms feel as prepared as they can be for the implementation of the EU Tobacco Products Directive (TPD), but many would still have liked to see it overturned by the European Court of Justice in the Totally Wicked case.
Essential facts about the new EU Tobacco Products Directive and its rules for e-cigarettes, which come into practical effect on 20th May 2016.
The number of products on the U.S. e-cigarette market will contract sharply after the new deeming regulations come into full effect, according to their architect the Food and Drug Administration (FDA) – and its predictions suggest a sudden slowdown in innovation too.
How will the new U.S. deeming regulations cover nicotine-free e-liquids and synthetic nicotine?
Members of the U.S. Congress, mostly Democrats, continue to welcome the Food and Drug Administration’s deeming rule extending its authority over tobacco to e-cigarettes and other products.
Some larger independent e-cigarette companies support the new rules from the U.S. Food and Drug Administration (FDA), despite the debate over them being widely portrayed as an argument between Big Tobacco and health organisations on one side versus indie e-cig firms on the other.
British politicians this week called on the government to justify its implementation of the EU Tobacco Products Directive (TPD).
U.S. media reactions to the new deeming rule ran the gamut from praise for an FDA which had produced “sensible regulations”, to damning criticism for an agency which will supposedly do more to promote smoking than to stop it.
While the U.S. deeming regulations and the EU’s TPD will come into effect almost simultaneously this summer, bringing some regulatory consistency and clarity to the world’s largest e-cigarette markets, their approaches could hardly be more different.
Several members of Congress welcomed what they view as a long-overdue rule by the U.S. Food and Drug Administration (FDA) to regulate e-cigarettes, but the initial responses also provided another opportunity for Democrats and Republicans to show how divided they are when it comes to adding new federal oversight.
Striving for science-based policy-making in the deeming regulations, the FDA faced a tough task in attempting to corral the rapidly-developing and often contradictory data on e-cigarettes at the same time as it was dealing with pleas and criticisms from the industry and pressure groups.
The Court of Justice of the European Union (ECJ) has ruled against the British e-cigarette company Totally Wicked in its quest to overturn article 20 of the EU Tobacco Products Directive (TPD).
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Get 7 days of FREE platform access: Demo our data contents without commitment
